Pages

Saturday, August 23, 2014

Viacyte Partners with Janssen on Diabetes Therapy

San Diego's ViaCyte has received $20 million from a drug company to advance its stem cell-based therapy for Type 1 diabetes into human clinical trials.

http://ift.tt/1AHjStb

No comments:

Post a Comment